The Myth of Moderation
- Rah Boz
- Oct 10
- 4 min read
“Everything in moderation” sounds comforting—but biology isn’t a slogan.

There is no single, universal threshold of “a little” sugar, alcohol, or ultra-processed food (UPF) that guarantees freedom from addiction-like eating or protection from metabolic disease. Individual risk depends on genetics, neurobiology, gut–liver metabolism, and mitochondrial resilience. Below is the science—kept practical.
Why “a safe amount” isn’t one-size-fits-all
Brains differ: Reward sensitivity and satiety signaling vary across people. Genetic variants in dopamine pathways (e.g., DRD2/ANKK1 Taq1A) are associated with higher odds of substance use disorders; similar circuits are recruited by highly palatable foods, helping explain why some people lose control at lower exposures than others.
No truly “safe” alcohol level: The World Health Organization concluded in 2023 that no amount of alcohol is risk-free for health; risk accumulates from the first drink. Population guidelines pick convenience cutoffs, not personal safety thresholds.
Ultra-processed foods and harm scale with exposure—but not linearly for everyone. Large umbrella reviews link higher UPF intake to more cardiometabolic disease, mental-health disorders, and mortality, yet individuals diverge widely in susceptibility due to biology and context.
The molecular physics of food: why formulation matters
“Food” isn’t just nutrients; it’s structure. Processing alters particle size, porosity, emulsification, and matrix—the physical form that governs how quickly molecules hit receptors in the mouth and gut.
Faster delivery, bigger signals. When starches and fats are finely milled, emulsified, and combined with sugars, they dissolve and absorb faster, producing steeper spikes in gut-derived hormones and dopamine, reinforcing cue-driven eating. Conceptualizing certain UPFs as “addictive” reflects these rapid pharmacokinetic-like properties.
Mitochondria: where “moderation” often fails
Mitochondria are your cellular power plants and redox hubs. Chronic overexposure to refined fats/sugars pushes them into dysfunction:
Lipotoxic overload: Surplus saturated fatty acids (e.g., palmitate) spill into non-adipose tissues, overwhelming mitochondrial β-oxidation, raising reactive oxygen species (ROS), triggering ER stress and inflammation, and ultimately injuring insulin-producing β-cells.
Redox and inflammasome activation: In obesity and insulin resistance, impaired oxidative phosphorylation and excess ROS activate the NLRP3 inflammasome, feeding a vicious cycle that worsens hepatic fat and β-cell failure.
Fructose and liver fat: Unlike glucose, fructose is rapidly shunted in the liver toward de novo lipogenesis (DNL), increasing triglyceride synthesis and hepatic steatosis—even independent of calories in some contexts.
From mitochondria to metabolic disease
When mitochondrial stress becomes chronic, risk rises for:
Insulin resistance and type 2 diabetes (via lipid accumulation, oxidative stress, β-cell apoptosis).
Non-alcoholic fatty liver disease (NAFLD/MASLD) through fructose-driven DNL and impaired fatty-acid oxidation.
Cardiovascular disease through dyslipidemia, endothelial dysfunction, and chronic inflammation—risks that scale with UPF exposure.
So, how much is “okay”?
Biology’s honest answer: it depends, and for some exposures (e.g., alcohol) the safest level for long-term health is zero. For UPFs, risk rises with dose, speed of delivery, and frequency, while individual vulnerability varies. There is no intake table that can guarantee you won’t slide into dependence-like patterns or metabolic injury.
A practical pivot: whole foods, plants first
You don’t need perfection—you need a center of gravity. Diets emphasizing whole, minimally processed plants (vegetables, fruits, legumes, whole grains, nuts, seeds) consistently show lower risk of type 2 diabetes and cardiovascular disease and support healthier mitochondrial function via fiber, polyphenols, and unsaturated fats:
Higher adherence to plant-based patterns → lower T2D risk in dose-response meta-analyses.
Plant-forward patterns → reduced CVD incidence and mortality.
Clinical and mechanistic reviews support plant-based approaches in diabetes prevention and care.
Bottom line
“Moderation” isn’t a shield—it’s a slogan. Because brains, genes, and mitochondria differ, the only universal rule is that more exposure to highly processed, rapidly absorbed mixtures (and alcohol) means more risk, with no magic personal threshold that guarantees safety. Centering a whole-foods, plant-based pattern is a high-probability way to reduce addiction-like eating and protect mitochondrial health—no guesswork thresholds required.
---
Sources
World Health Organization. No level of alcohol consumption is safe for our health. 2023.
Anderson BO et al. Health and cancer risks associated with low levels of alcohol consumption. Lancet Public Health. 2023.
Lane MM et al. Ultra-processed food exposure and adverse health outcomes: umbrella review. BMJ. 2024.
Gearhardt AN et al. Social, clinical, and policy implications of ultra-processed food addiction. BMJ. 2023.
LaFata EM et al. Ultra-Processed Food Addiction: A Research Update. Curr Addict Rep. 2024.
Chen B et al. Lipotoxicity: A New Perspective in Type 2 Diabetes Mellitus. Int J Mol Sci. 2025.
Choi W et al. Obesity-Driven Metabolic Disorders: The Interplay of Oxidative Stress, Mitochondrial Dysfunction, and Inflammation. Int J Mol Sci. 2025.
Geidl-Flueck B & Stöckli J. Fructose drives de novo lipogenesis affecting metabolic disease. J Endocrinol. 2023.
Softic S et al. Role of Dietary Fructose and Hepatic de novo Lipogenesis in NAFLD. Hepatology (review). 2016.
Zhu Z et al. In-depth analysis of de novo lipogenesis in NAFLD. Metabolism Open. 2023.
Jung Y-C et al. DRD2 Taq1A and alcohol use disorder: meta-analysis. JAMA Netw Open. 2019.
Gan ZH et al. Plant-based diets and CVD: systematic review and meta-analysis. Clin Nutr. 2021.
Quek J et al. Plant-Based Diet and CVD Outcomes. Front Cardiovasc Med. 2021.
Qian F et al. Plant-Based Dietary Patterns and Type 2 Diabetes. JAMA Intern Med. 2019.
Jardine MA et al. Plant-Based Eating for T2D Prevention and Treatment. Nutrients. 2021.



Comments